IRCT20221230056991N1
Recruiting
Phase 3
Comparison of the effectiveness of combined treatment of topical minoxidil and PRP(platelet rich plasma) with topical minoxidil alone in patients with moderate to severe female androgenetic alopecia referred to educational clinics Isfahan University of Medical Sciences
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Androgenetic alopecia.
- Sponsor
- Esfahan University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients willing to participate in the study
- •Confirmatory diagnosis of androgenetic alopecia disease by two experts with skin and hair experience
- •Women aged 18 to 60 years
- •Moderate to severe hair loss
Exclusion Criteria
- •Patients suffering from other types of alopecia (such as alopecia areata, telogen effluvium, anagen effluvium and scarring alopecias)
- •Patients with active psoriasis or active lichen planus due to the positive Köbner phenomenon in these diseases
- •Any serious systemic disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Comparison of the effectiveness of combined treatment of topical L-carnitine lotion 1% with clotrimazole lotion 2% and clotrimazole lotion 2% alone in the treatment of seborrheic dermatitis of the head (scalp)IRCT20150706023081N4Esfahan University of Medical Sciences64
Not yet recruiting
Phase 2
Effectiveness of Combined Treatment of Carboxytherapy, Platelet-Rich Plasma (PRP) and Local Finasteride with Platelet-Rich Plasma in the Treatment of Androgenic Hair LossAndrogenic hair loss.Cicatricial alopecia [scarring hair loss]IRCT20220919055994N1Kerman University of Medical Sciences20
Not yet recruiting
Phase 2
Comparison of outcomes of single drug therapy versus dual drug therapy in the treatment of hemodynamically significant PDAHealth Condition 1: Q250- Patent ductus arteriosusCTRI/2024/05/066914Govind Choudhary
Completed
Not Applicable
Comparison of the therapeutic benefit to combination therapy of botulinum neurotoxin and cast as well as single dose of botulinum neurotoxin on the wrist spasticity in different time intervalsG81.1I63.9Spastic hemiplegiaCerebral infarction, unspecifiedDRKS00010413eurologisches Rehabilitationszentrum Leipzig60
Not yet recruiting
Phase 4
comparison of newer and higher dose antibiotics combination therapy with old and standard antibiotics combination therapy in critically ill patients who are carbapenem resistant enterobacteriaceae (CRE)Health Condition 1: R799- Abnormal finding of blood chemistry, unspecifiedCTRI/2022/09/045736Department of Anaesthesiology and Critical and Care Jawaharlal Nehru Medical College AMU Aligarh